First-Ever-Study-of-NYC-Primary-Care-DoctorsResponse-to-Anthrax
Primary care physicians — working only blocks away from the New York City anthrax attacks of October 2001 — acted responsibly and rationally in the midst of the crisis, according to NewYork-Presbyterian Hospital/Weill Cornell Medical Center researchers.
Head-Cooling-Device-Prevents-Brain-Damage-in-Oxygen-Deprived-Inf
Morgan Stanley Children's Hospital Is Only NYC Study Center
A head-cooling device called CoolCap prevents brain damage in some oxygen-deprived newborn babies, providing the first evidence in humans that many birth-related neurological problems can be reversed, according to an international multi-center clinical trial that included physician-scientists at Morgan Stanley Children's Hospital of NewYork-Presbyterian, the only New York City medical center to participate in the study.
Reducing-Enlarged-Heart-Muscle-Cuts-Patients-Cardiac-Risk
Findings from both echocardiogram and electrocardiogram (ECG) suggest that anti-hypertensive drugs that aggressively shrink enlarged heart muscle bring added benefits to patients, lowering their risk for dangerous cardiovascular events.
First-NYC-Patient-Receives-New-Alternative-to-Open-Heart-Surgery
A 61-old man was the first in the New York City-area to receive a new, less-invasive alternative to open-heart surgery with the Evalve® Cardiovascular Valve Repair System (CVRS) to treat mitral valve regurgitation (MR). Physician-scientists at NewYork-Presbyterian Hospital/Columbia are conducting a Phase I clinical trial of the new treatment. At present, surgery is the only effective method of treatment for severe chronic MR, a defect in which the heart's mitral valve fails to close properly, resulting in abnormal flow of blood, weakening of the heart, and potentially leading to congestive heart failure.
Common-Bone-Complications-in-Advanced-Prostate-Cancer-Patients
Bone complications associated with prostate cancer cause a substantial economic burden, according to a new study led by a physician-scientist at NewYork-Presbyterian Hospital/Columbia University Medical Center and presented today at the American Society of Clinical Oncology's (ASCO) 40th Annual Meeting in New Orleans.
Weill-Cornell-Professor-Honored-With-Lifetime-Achievement-Award
Dr. Bernice Grafstein, a noted expert in the field of neuroregeneration research and the Vincent and Brooke Astor Distinguished Professor in Neuroscience at Weill Cornell Medical College, has been honored with Women in Neuroscience's prestigious 2003 Mika Salpeter Lifetime Achievement Award. The award was presented to Dr. Grafstein in conjunction with the 2003 Society for Neuroscience Meeting, the major annual scientific event for the neurosciences.
Getting-to-the-Heart-of-Alzheimers-NYP-Cornell-Physician-Scienti
Subtle but profound changes in blood flow within the brain may be among the earliest signs of Alzheimer's disease, according to a review of recent research conducted by Dr. Costantino Iadecola, Chief of the Division of Neurobiology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, in New York City.
Breast-Cancer-Drug-Taxotere-Extends-Life-of-Prostate-Cancer
Men with androgen-independent (hormone-refractory) metastatic prostate cancer treated with the breast-cancer drug Taxotere® (docetaxel) Injection Concentrate in combination with the drug estramustine survived 20 percent longer than similar patients receiving the standard therapy, according to a landmark Phase III study authored by physician-scientists at NewYork-Presbyterian Hospital/Columbia University Medical Center, and published in today's New England Journal of Medicine.
Page228 of 334